Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline

• Published in: Actas dermo-sifiliográficas (English ed.) Vol. 111; no. 4; pp. 291 - 299
• Main Authors: Vílchez-Márquez, F, Borregón-Nofuentes, P, Barchino-Ortiz, L, Ruíz-de-Casas, A, Palacios-Álvarez, I, Soria-Rivas, A, Descalzo-Gallego, M A, García-Doval, I, Ríos-Buceta, L, Redondo-Bellón, P
• Format: Journal Article
• Language: English; Spanish
• Published: 01.05.2020
• ISSN: 1578-2190
• DOI: 10.1016/j.ad.2019.07.006

BACKGROUND AND OBJECTIVEBasal cell carcinoma (BCC) is the most common skin cancer in the general population. BCC is managed in a variety of ways, and available international guidelines are difficult to put into practice in Spain. This guideline aims to improve the management of BCC based on current evidence and provide a point of reference for Spanish dermatologists.MATERIAL AND METHODSMembers of the Spanish Oncologic Dermatology and Surgery Group (GEDOC) with experience treating BCC were invited to participate in drafting this guideline. The drafters used the ADAPTE collaboration process to develop the new guideline based on existing ones, first summarizing the care pathway and posing relevant clinical questions. They then searched for guidelines, assessed them with the AGREEII (Appraisal of Guidelines for Research and Evaluation) tool, and searched the selected guidelines for answers to the clinical questions. Finally, the recommendations were drafted and submitted for external review.RESULTSThe highest-scoring guidelines were from the Association of Dermatologists, the National Comprehensive Cancer Network, the European Dermatology Forum, and the European Academy of Dermatology and Venereology. A total of 11 clinical questions were answered.CONCLUSIONSThis new guideline answers the working group's clinical questions about the routine management of BCC in Spain. It provides dermatologists with a tool they can use for decision-making while taking into consideration the resources available and patient preferences.